Detalles de la búsqueda
1.
Function of Presynaptic Inhibitory Cannabinoid CB1 Receptors in Spontaneously Hypertensive Rats and Its Modification by Enhanced Endocannabinoid Tone.
Int J Mol Sci
; 25(2)2024 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38255931
2.
Weak Hypotensive Effect of Chronic Administration of the Dual FAAH/MAGL Inhibitor JZL195 in Spontaneously Hypertensive Rats as Revealed by Area under the Curve Analysis.
Int J Mol Sci
; 24(13)2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37446125
3.
Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance.
Int J Mol Sci
; 23(11)2022 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35683028
4.
GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries.
Int J Mol Sci
; 23(3)2022 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35163351
5.
Chronic cannabidiol treatment reduces the carbachol-induced coronary constriction and left ventricular cardiomyocyte width of the isolated hypertensive rat heart.
Toxicol Appl Pharmacol
; 411: 115368, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338514
6.
Beneficial and harmful effects of CB1 and CB2 receptor antagonists on chronotropic and inotropic effects related to atrial ß-adrenoceptor activation in humans and in rats with primary hypertension.
Clin Exp Pharmacol Physiol
; 48(11): 1547-1557, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333780
7.
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.
Int J Mol Sci
; 22(4)2021 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671463
8.
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism.
Int J Mol Sci
; 21(4)2020 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075117
9.
Engineered Context-Sensitive Agonism: Tissue-Selective Drug Signaling through a G Protein-Coupled Receptor.
J Pharmacol Exp Ther
; 360(2): 289-299, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082514
10.
Role of the Histamine H3 Receptor in the Central Nervous System.
Handb Exp Pharmacol
; 241: 277-299, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27787717
11.
Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria.
Front Pharmacol
; 15: 1382995, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873412
12.
Polypharmacology: promises and new drugs in 2022.
Pharmacol Rep
; 75(4): 755-770, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37278927
13.
Acute myocardial infarction inhibits the neurogenic tachycardic and vasopressor response in rats via presynaptic cannabinoid type 1 receptor.
J Pharmacol Exp Ther
; 343(1): 198-205, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22798198
14.
Cross-Talk between CB1, AT1, AT2 and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls.
Cells
; 11(9)2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563848
15.
Eighth pharmacologic-historical forum.
Naunyn Schmiedebergs Arch Pharmacol
; 395(9): 1125-1137, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790575
16.
Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?
Cells
; 11(7)2022 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35406706
17.
Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.
Front Pharmacol
; 13: 965613, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36120288
18.
ß1-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure.
Front Cardiovasc Med
; 8: 639562, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179127
19.
Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part II. Some contributions of Manfred Göthert.
Pharmacol Rep
; 72(2): 271-284, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048263
20.
Reduction of the serotonin 5-HT1B and 5-HT2A receptor-mediated contraction of human pulmonary artery by the combined 5-HT1B receptor antagonist and serotonin transporter inhibitor LY393558.
Pharmacol Rep
; 72(3): 756-762, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333296